Background illustration for clinical trials search

Paid Clinical Trials Kent

Discover 1,441 paid clinical trials in Kent, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

for
Hepatocellular Carcinoma
Location: Seattle WA, Edmonton, Palo Alto CA, Los Angeles CA,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06921785

Phase3, Recruiting

Double-blind, Randomized, Placebo-controlled, Multicenter Study to Evaluate the Efficacy and Safety of Ravulizumab Administered Intravenously in Adult Participants at High Risk of Delayed Graft Function After Kidney Transplantation

for
Delayed Graft Function, DGF, Kidney Transplant
Location: Seattle WA, Vancouver, Edmonton, San Francisco CA,
Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All

Age: 18+

Code: NCT06830798

Phase3, Recruiting

ELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP)

for
Acute Hepatic Porphyria
Location: Seattle WA, San Francisco CA, Salt Lake City UT,
Sponsor: Alnylam Pharmaceuticals

Sex: All

Age: 12+

Code: NCT04883905

Recruiting

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

for
Acute Coronary Syndrome
Location: Seattle WA, Abbotsford British Columbia, Burnaby,
Sponsor: DalCor Pharmaceuticals

Sex: All

Age: 45+

Code: NCT05918861

Phase3, Recruiting

A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure

for
Chronic Kidney Disease and Hypertension
Location: Seattle WA, Surrey, Springfield OR, Edmonton,
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT06742723

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

for
Lupus Erythematosus, Systemic
Location: Seattle WA, San Francisco CA, St Louis MO, Atlanta GA,
Sponsor: AstraZeneca

Sex: All

Age: 18 - 70

Code: NCT06897930

Phase1, Phase2, Recruiting

A Study on the Safety and Immune Response of a Urinary Tract Infection (UTI) Vaccine in Adults 18-64 Years of Age and Clinical Efficacy in Females 18-64 Years of Age

for
Urinary Tract Infections
Location: Seattle WA, Wenatchee WA, Lenexa KS, Weatherford TX,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 64

Code: NCT06702449

Phase1, Phase2, Recruiting

NA-831, Atazanavir and Dexamethasone Combination Therapy for the Treatment of COVID-19 Infection

for
Coronavirus Infection, Severe Acute Respiratory Infection,
Location: Seattle WA, Kirkland WA, Tacoma WA, Sacramento CA,
Sponsor: Biomed Industries, Inc.

Sex: All

Age: 18 - 70+

Code: NCT04452565

Phase2, Phase3, Recruiting

A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)

for
Solid Tumors, Neoplasms
Location: Seattle WA, Portland OR, Santa Rosa CA,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06431594

Phase1, Recruiting

A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults

for
Influenza, Human+COVID-19
Location: Seattle WA, Fair Oaks CA, San Diego CA, Austin TX,
Sponsor: GlaxoSmithKline

Sex: All

Age: 65 - 70+

Code: NCT07464314

Phase1, Recruiting

A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)

for
HIV Infections
Location: Seattle WA, Bakersfield CA, West Hollywood CA,
Sponsor: ViiV Healthcare

Sex: All

Age: 18+

Code: NCT07202546

Phase2, Recruiting

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

for
Obesity With Diabetes, Overweight With Diabetes
Location: Seattle WA, Missoula MT, Pleasant View UT,
Sponsor: Kailera

Sex: All

Age: 18+

Code: NCT07284901

Phase3, Recruiting

Study of Olverembatinib (HQP1351) in Patients With CML-CP

for
Chronic Myeloid Leukemia, CML, CML, Chronic Phase
Location: Seattle WA, Issaquah WA, Edmonds WA, Reno NV,
Sponsor: Ascentage Pharma Group Inc.

Sex: All

Age: 18+

Code: NCT06423911

Phase3, Recruiting

First Responder Airway & Compression Rate Trial

for
Out-Of-Hospital Cardiac Arrest
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT05969028

Recruiting

Assessment of the Safety, Tolerability, and Effectiveness of Rifapentine Given Daily for LTBI

for
Latent Tuberculosis
Location: Seattle WA, Vancouver, Calgary, Edmonton, Denver CO,
Sponsor: Centers for Disease Control and Prevention

Sex: All

Age: 0+

Code: NCT03474029

Phase2, Phase3, Recruiting

Prevention of Shaken Baby Syndrome

for
Child Abuse, Shaken Baby Syndrome
Location: Seattle WA
Sponsor: Harborview Injury Prevention and Research Center

Sex: All

Age: 0

Code: NCT00105963

Recruiting

Overdose Recovery and Care Access (ORCA) Qualitative Stakeholder Interviews and County-level Data

for
Opioid Use Disorder, Opioid Use
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT06768814

Recruiting

Electronic Harm Reduction Treatment for Alcohol

for
Alcohol Use Disorder, Harm Reduction,
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 21+

Code: NCT06702007

Phase3, Recruiting
New

WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency Department

for
Acute Hypoxic Respiratory Failure,
Location: Seattle WA, Murray UT, Tucson AZ, Ann Arbor MI,
Sponsor: Ohio State University

Sex: All

Age: 18+

Code: NCT07558265

Recruiting

StrokeNet Thrombectomy Endovascular Platform

for
Ischemic Stroke
Location: Seattle WA, Stanford CA, Salt Lake City UT,
Sponsor: Medical University of South Carolina

Sex: All

Age: 18+

Code: NCT06289985

Recruiting